Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: Open-End Fund
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: Global

NLB Skladi - Farmacija in zdravstvo delniski

+ Add to Watchlist

NLBFARM:SV

8.36 EUR 0.05 0.62%

As of 00:59:30 ET on 02/26/2015.

Snapshot for NLB Skladi - Farmacija in zdravstvo delniski (NLBFARM)

Year To Date: +11.61% 3-Month: +13.85% 3-Year: +26.50% 52-Week Range: 5.81 - 8.36
1-Month: +1.46% 1-Year: +34.89% 5-Year: +17.08% Beta vs SBITOP: 0.38

Mutual Fund Chart for NLBFARM

No chart data available.
  • NLBFARM:SV 8.36
  • 1M
  • 1Y
Interactive NLBFARM Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for NLBFARM

NLB Skladi - Farmacija in zdravstvo delniski (Equity Pharma & Health Care) is an open-end fund incorporated in Slovenia. The Fund aims to invest in global equities from pharmaceutical and biotechnology, healthcare equipment and services and life & health insurance sectors. The Fund's expects price growth of these equities in case of continued higher expenditure for healthcare.

Inception Date: 01-19-2006 Telephone: +386 1 476 5270
Managers: KRUNO ABRAMOVIC / ALEKSANDRA BRDAR TURK
Web Site: www.nlbskladi.si

Fundamentals for NLBFARM

NAV (on 2015-02-26) 8.36
Assets (M) (on 2010-04-30) 4.14
Fund Leveraged N
Minimum Investment -
Minimum Subsequent Investment -

Dividends for NLBFARM

No dividends reported

Fees & Expenses for NLBFARM

Front Load -
Back Load -
Current Mgmt Fee 1.75
Redemption Fee -
12b1 Fee -
Expense Ratio 2.14

Top Fund Holdings for NLBFARM

Filing Date: 01/30/2015
Name Position Value % of Total
Krka dd Novo mesto 24,035 1,393,790 3.132%
Teva Pharmaceutical Industries 26,900 1,352,971 3.040%
Baxter International Inc 20,500 1,274,971 2.865%
Medtronic PLC 19,243 1,215,347 2.731%
Novartis AG 14,000 1,205,674 2.709%
Bayer AG 9,350 1,195,042 2.686%
UnitedHealth Group Inc 12,200 1,146,617 2.577%
Abbott Laboratories 28,800 1,140,281 2.562%
Sanofi 13,400 1,098,800 2.469%
Eli Lilly & Co 17,200 1,095,444 2.462%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil